It's been a very different year so far for two big pharma stocks: One's hot and one's not. Things are going great for GlaxoSmithKline plc (NYSE: GSK)as its share price is up around 15% year to date. But for Johnson & Johnson (NYSE: JNJ), it's a different story. J&J stock is down more than 10% in 2018.
Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться